Member of the UK's Academy of Medical Sciences , Director of the Australian National Phenome Centre , Pro Vice-Chancellor of Health Sciences at Murdoch University, Australi

Jeremy Kirk Nicholson

Academician
One of the pioneers of biological NMR spectroscopy, metabolic phenotyping and precision systems medicine, Nicholson’s major research focus is on the development of diagnostic and prognostic molecular phenotyping technologies as applied to personalised healthcare, metabolic disease, and population phenotyping. His research group currently specialises in the discovery and development of immuno-metabolic models of inflammatory diseases and their translational application in the clinic. Professor Nicholson obtained his PhD from King’s College London in 1980. After a series of academic appointments in Pharmacology and Chemistry at Birkbeck and University College London, he was made full Professor of Biological Chemistry in 1992. He was appointed as Professor and Head of Biological Chemistry at Imperial College London in 1998, Head the Department of Surgery and Cancer (2009-2018), Director for the Centre for Gut and Digestive Health, and Director of the MRC-NIHR National Phenome Centre (2012-2018), Emeritus Professor (2018 onwards). He became the Pro-Vice Chancellor for Health Sciences at Murdoch University and Director of the Australian National Phenome Centre in Perth, Western Australia in 2019.

He is a “Highly-Cited” Researcher in Pharmacology and Toxicology and Cross-Field Science 2014-2024 (Google H = 172, 128K citations) and has received various research prizes including: The Royal Society of Chemistry (RSC) Silver (1992) and Gold (1997) Medals for Analytical Science and Analytical Chemistry; The UK Chromatographic Society Jubilee Silver Medal (1994); Pfizer International Prize for Chemical and Medicinal Technology (2002); RSC medal for Chemical Biology (2003); RSC Interdisciplinary Prize (2008); Pfizer Global Research Prize for Chemistry (2006) and the Semmelweis-Budapest Prize for Biomedicine (2010). He holds multiple visiting, and Honorary Professorships including Fudan University, Shanghai, The Mayo Clinic, University of New South Wales, Khon Kaen University, Thailand, Shanghai Jiao Tong University, Zhejiang University, University of Western Australia, Chinese Academy of Sciences, Wuhan, and Dalian. He was elected, Fellow of The UK Academy of Medical Sciences in 2010; Honorary Lifetime Fellow of the International Metabolomics Society in 2012; Honorary Lifetime Member of the US Society of Toxicology in 2013; Albert Einstein Honorary Professor of the Chinese Academy of Sciences in 2014; Elected Honorary Fellow of the Royal College of Physicians (London, 2018); Honorary Doctor of Science, Honoris Causa (Hong Kong Baptist University, 2020). His contributions to the global scientific community have strongly influenced the fields of analytical spectroscopy, metabolic medicine, precision healthcare and preventive medicine. His current work is focussed on large scale population phenomics, healthy aging and disease prevention.